Asthma and COPD Devices Market,Share,Size,Forecast 2026
In October 2018, Philips launched InnoSpire Go, a smallest and lightest portable hand-held nebulizer. InnoSpire Go is available in the United States and additional countries including Australia, Denmark, Finland, Germany, Norway, and the United Kingdom.
(EMAILWIRE.COM, September 12, 2019 ) Market Overview:
Asthma is a chronic disease that makes breathing difficult, an inflammation of the air passages in a temporary narrowing of the airways that carry oxygen to the lungs.
The global asthma and COPD devices market was worth $ XX billion in 2018 and is forecasted to reach $ XX billion by 2026, at a CAGR of XX% during the forecast period.
Market Dynamics:
The rising prevalence of chronic diseases is one of the factor fueling the global asthma and COPD devices market.
Market Segmentation:
BY PRODUCT TYPE
• Inhalers
• Nebulizers
BY DISTRIBUTION CHANNEL
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
Geographical Analysis:
The Asthma and COPD devices market is segmented into:
• North America
• Europe
• Asia Pacific
• South America
• The Middle East and Africa
Competitive Analysis:
Key Players:
• Boehringer Ingelheim International GmbH
• Merck & Co., Inc.
• GlaxoSmithKline PLC.
• Novartis AG
• AstraZeneca
• Baxter International
View full report: https://www.datamintelligence.com/research-report/asthma-and-copd-devices-market
Download free sample: https://www.datamintelligence.com/download-sample/asthma-and-copd-devices-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Asthma is a chronic disease that makes breathing difficult, an inflammation of the air passages in a temporary narrowing of the airways that carry oxygen to the lungs.
The global asthma and COPD devices market was worth $ XX billion in 2018 and is forecasted to reach $ XX billion by 2026, at a CAGR of XX% during the forecast period.
Market Dynamics:
The rising prevalence of chronic diseases is one of the factor fueling the global asthma and COPD devices market.
Market Segmentation:
BY PRODUCT TYPE
• Inhalers
• Nebulizers
BY DISTRIBUTION CHANNEL
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
Geographical Analysis:
The Asthma and COPD devices market is segmented into:
• North America
• Europe
• Asia Pacific
• South America
• The Middle East and Africa
Competitive Analysis:
Key Players:
• Boehringer Ingelheim International GmbH
• Merck & Co., Inc.
• GlaxoSmithKline PLC.
• Novartis AG
• AstraZeneca
• Baxter International
View full report: https://www.datamintelligence.com/research-report/asthma-and-copd-devices-market
Download free sample: https://www.datamintelligence.com/download-sample/asthma-and-copd-devices-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results